Related references
Note: Only part of the references are listed.Molecular mechanisms regulating NLRP3 inflammasome activation
Eun-Kyeong Jo et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
The intersection of cell death and inflammasome activation
James E. Vince et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1/IL-1R1/MyD88/NF-B pathway
Cheng Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
NLRP3 deletion protects against renal fibrosis and attenuates mitochondrial abnormality in mouse with 5/6 nephrectomy
Wei Gong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Novel Roles for Caspase-8 in IL-1β and Inflammasome Regulation
Prajwal Gurung et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
The Protective Mechanism of Fluorofenidone in Renal Interstitial Inflammation and Fibrosis
Yiting Tang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2015)
Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice
Hiroyuki Kadoya et al.
FASEB JOURNAL (2015)
NLRP3 at the interface of metabolism and inflammation
Moritz Haneklaus et al.
IMMUNOLOGICAL REVIEWS (2015)
Fluorofenidone inhibits macrophage IL-1β production by suppressing inflammasome activity
Miaomiao Lu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Ghrelin Attenuates Renal Fibrosis and Inflammation of Obstructive Nephropathy
Guang-Xi Sun et al.
JOURNAL OF UROLOGY (2015)
Fluorofenidone protects against renal fibrosis by inhibiting STAT3 tyrosine phosphorylation
Juan Tang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome
Chul-Su Yang et al.
NATURE COMMUNICATIONS (2015)
Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells
Yu Peng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Inflammatory processes in renal fibrosis
Xiao-Ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2014)
Nlrp3 Prevents Early Renal Interstitial Edema and Vascular Permeability in Unilateral Ureteral Obstruction
Wilco P. Pulskens et al.
PLOS ONE (2014)
Fluorofenidone Offers Improved Renoprotection at Early Interventions during the Course of Diabetic Nephropathy in db/db Mice via Multiple Pathways
Xuan Xiong et al.
PLOS ONE (2014)
CARD8 is a negative regulator for NLRP3 inflammasome, but mutant NLRP3 in cryopyrin-associated periodic syndromes escapes the restriction
Sayaka Ito et al.
ARTHRITIS RESEARCH & THERAPY (2014)
The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways
Yu Peng et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
FLUOROFENIDONE ATTENUATES BLEOMYCIN-INDUCED PULMONARY INFLAMMATION AND FIBROSIS IN MICE VIA RESTORING CAVEOLIN 1 EXPRESSION AND INHIBITING MITOGEN-ACTIVATED PROTEIN KINASE SIGNALING PATHWAY
Jie Meng et al.
SHOCK (2012)
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Charles A. Dinarello
BLOOD (2011)
A clinical perspective of IL-1β as the gatekeeper of inflammation
Charles A. Dinarello
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Fluorofenidone inhibits Ang II-induced apoptosis of renal tubular cells through blockage of the Fas/FasL pathway
Wang-bin Ning et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Fluorofenidone attenuates renal interstitial fibrosis in the rat model of obstructive nephropathy
Bing-xin Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
Fluorofenidone protects mice from lethal endotoxemia through the inhibition of TNF-α and IL-1β release
Yiting Tang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
The NLRP3 Inflammasome Promotes Renal Inflammation and Contributes to CKD
Akosua Vilaysane et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Mechanistic connection between inflammation and fibrosis
Soo Bong Lee et al.
KIDNEY INTERNATIONAL (2010)
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Jurg Tschopp et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Inflammatory cells in renal injury and repair
David Ferenbach et al.
SEMINARS IN NEPHROLOGY (2007)
Progression in chronic kidney disease
AA Eddy
ADVANCES IN CHRONIC KIDNEY DISEASE (2005)
Pentoxifylline attenuates tubulointerstitial fibrosis by blocking Smad3/4-activated transcription and profibrogenic effects of connective tissue growth factor
SL Lin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Normalization of brain death-induced injury to rat renal allografts by recombinant soluble P-selectin glycoprotein ligand
M Gasser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Share Paper
